Acquisition machine versus accompaniment program: optimized checkout against structured coaching around the prescription.
The two models
Hims is the category’s marketing heavyweight with its most contested model: after its Novo Nordisk partnership collapsed in June 2025, it leaned into “personalized” compounded semaglutide — the legal rationale regulators and manufacturers dispute most directly. Advertised entry prices are aggressive; true maintenance-dose totals are exactly what our pending verification exists to establish.
Found bundles medication access with structured coaching and insurance navigation — a genuinely different product than pure medication funnels, aimed at people who want a program around the prescription. Program fees versus medication costs, and what the coaching layer actually adds, sit in our pending queue.
Verified vs pending — read this before the marketing
Neither provider on this page has completed price verification, so this comparison stays structural — business models, pricing architecture, and the questions each must answer — with zero advertised numbers repeated as facts. The only verified figures on this site today sit in the ledger.
What happens after the first fill
The models diverge exactly where journeys get hard: month four’s plateau, the adherence trough, the maintenance question. A funnel’s economics peak at signup; a program’s pitch is that its value peaks later. Whether Found’s coaching layer earns its fee — and what Hims’ true maintenance totals run — are both queued questions, so choose today on which failure mode you’re insuring against, not on either’s advertised math.
Go deeper
Full files: Hims · Found. Decision tools: the quiz routes by coverage and priorities; the calculator turns any quote into a true 12-month number; the ledger holds every verified figure and every pending slot.